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Abstract 
Marine biotoxins are widespread in the environment and impact on human health via 
contaminated shellfish, causing diarrhetic, amnesic, paralytic or neurotoxic poisoning. In spite of 
this methods for determining if poisoning has occurred are limited. We show the development of 
a simple and sensitive luminescence resonance energy transfer (LRET) -based concept which 
allows the detection of anti-okadaic acid rabbit polyclonal IgG (mouse monoclonal IgG1) using 
functionalized lanthanide-based nanoparticles. Upon UV excitation, the functionalized 
nanoparticles were shown to undergo LRET with fluorophore-labeled anti-okadaic acid 
antibodies which had been captured and bound by okadaic acid-decorated nanoparticles. The 
linear dependence of fluorescence emission intensity with antigen-antibody binding events was 
recorded in the nanomolar to micromolar range, while essentially no LRET signal was detected 
in the absence of antibody. These results may find applications in new, cheap and robust sensors 
for detecting not only immune responses to biotoxins but to a wide range of biomolecules based 
on antigen-antibody recognition systems. Further, as the system is based on solution chemistry it 
may be sufficiently simple and versatile to be applied at point-of-care. 
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Introduction 
Biosensors, based on the detection of targets using biomolecules, have become 
commonplace in today’s world. Such sensors, employing various physiologically-relevant 
biomolecules have found widespread use in diverse areas, ranging from pathogen detection to 
diagnosis and tracking of disease progression in humans.1 While many biosensors have 
traditionally focused on the use of antibodies for antigen detection, the detection of antibodies is 
increasingly recognized as an important aspect of biosensor research. Antibodies may be used as 
biomarkers for following a range of illnesses including tuberculosis,2 human papillomavirus,3 
and breast cancer.4 In addition, various conditions such as inflammatory bowel disease or HIV 
infection 5 may also be followed based on tracking changes to systemic antibody response to gut 
microbes when the latter’s balance is disrupted as a consequence of the disease. Further, 
determination of antibody presence and concentration provide valuable information on the 
efficacy of vaccines in inducing an immune response against specific targets such as, for 
example, malaria.6 
 
In recent years a range of techniques has been developed for the detection and 
quantification of antibodies against specific antigens, peptides, proteins and various 
biomolecules. Primary among these are methods derived from enzyme-linked immunosorbent 
assay (ELISA) in which a complementary biomolecule to the antibody is immobilized on a 
substrate and, upon binding of the antibody, may be labeled with a fluorescent dye which is 
interrogated to determine its concentration and by extension the concentration of antibody 
present. This method has been applied to the detection of a broad spectrum of antibodies ranging 
from those against Helicobacter pylori 7 to markers in rheumatoid arthritis,8,9 lupus 10 and 
heparin-induced thrombosis.11 Other related fluorescent marker approaches include, for example, 
immunoprecipitation assays and recombinant immunofluorescence assays for detection of 
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antibodies to aquaporin-4 in patients with neuromyelitis optica.12,13 Increasingly, these sensing 
techniques are being developed as antigen-bound micro-arrays in which large numbers of 
antigens are anchored to a substrate to show good sensitivity and low detection limit due to a 
high fluorescence signal, or a combination of antigens are bound providing a multiparametric 
sensor for a range of antibodies.10,14 
 
An alternative highly sensitive approach to antibody detection and quantification may 
potentially be based on exploiting resonance energy transfer, a technique based on the excited-
state non-radiative energy transfer between specific donor-acceptor pairs due to dipole-dipole 
interactions and spatial proximity, with the sensitivity of the technique down to the single target 
molecule level already having been shown.15 In fact, the use of fluorescence resonance energy 
transfer from functionalized terbium chelates to fluorescent organic dyes based on antibody-
antigen binding for the detection of total prostate specific antigen has recently been reported.16 A 
different concept based on the forced separation of a donor/acceptor pair upon binding to an 
anti-HIV-1-p17 antibody leading to FRET quenching hence allowing antibody concentration 
estimation was also recently reported.17  
 
Further development of these fluorescence techniques may be achieved through taking 
advantage of the unique optical properties of nano-sized materials. Application of lanthanide-
based nanoparticles as donors in such types of assay (luminescence resonance energy transfer; 
LRET) may be promising for a number of reasons including large Stokes′ shifts, thus avoiding 
direct excitation of the acceptor, and reduction of background emission in some applications.18 
Further, they have high quantum yields and very narrow emission bands compared to organic 
fluorophores, and long-lived excited state lifetimes (~1 ms) enable both facile measurement of 
donor lifetime changes and elimination of short-lived background auto-fluorescence by signal 
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collection after specific time delays.19,20 Indeed, detection of resonance energy transfer at the 
single lanthanide nanoparticle level has also been reported.21 Thus, biosensors based on nano-
materials may offer significant advantages over those currently in use in terms of sensitivity. The 
application of such a fluorescence technique, based on straightforward mix-and-measure 
solution chemistry, holds the promise for simple, rapid and cheap biosensors that may be applied 
at point-of-care. In this direction we show herein the ability to detect specific antibodies arising 
from exposure to the environmental biotoxin okadaic acid, a potent serine/threonine protein 
phosphatase 2A inhibitor and tumor promoter,22-24 by concentration-dependent resonance energy 
transfer in what may be a useful new method in the analytical chemist’s toolbox for the 
development of point-of-care diagnostic sensors. 
 
Experimental Methods 
Lanthanum nitrate and terbium nitrate (99.99%) were obtained from Sigma while cerium 
nitrate (99.9%) was supplied by Fluka. Sodium fluoride (p.a.) was received from Kemika, and 
ammonium hydroxide (ACS, 28.8-30% NH3 basis) and O-phosphorylethanolamine from Sigma. 
For all aqueous solutions, ultrapure water (18 MΩ) was used. Rabbit polyclonal antibodies to 
okadaic acid were obtained from Abcam (Cambridge, UK) while goat anti-rabbit IgG Fab and 
AlexaFluor 488 fluorescent dye were supplied by Life Technologies. 
 
Synthesis of LaF3:Ce,Tb nanoparticles 
All precursor materials were obtained at the highest possible purity and used as received 
(supplementary information, SI). The synthesis of water soluble and amino-capped 
La0.40F3:Ce0.45,Tb0.15 nanoparticles (LaNPs) was carried out based on the method of Diamente et 
al. 25 with some small modifications. Briefly, to a NH4OH-neutralized aqueous solution (25 mL) 
of 144 mg (1 mmol) O-phosphorylethanolamine was added 130 mg (3 mmol) NaF. The solution 
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was heated to 40°C upon which a solution of La(NO3)3·6H2O (540 mg, 1.26 mmol), 
Ce(NO3)3·6H2O (580 mg, 1.34 mmol) and Tb(NO3)3·6H2O (240 mg, 0.56 mmol) in 2 mL 
ultrapure water was added drop wise. The solution was held at 40°C overnight upon which the 
nanoparticles were precipitated with acetone, isolated by centrifugation (10 min at 3000 rpm), 
washed with acetone and centrifuged again. 
 
Covalent conjugation of okadaic acid to LaF3:Ce,Tb nanoparticles 
Okadaic acid was first activated by reaction with N-hydroxysuccinimide (NHS) and N-(3-
dimethylaminopropyl)-N`-ethylcarbodiimide hydrochloride (EDAC). NHS (12 mg) and EDAC 
(19 mg) were dissolved in 1 mL 2-(N-morpholino)ethanesulfonic acid (MES) buffer (100 mM, 
pH 6.0). A 20 μL aliquot was withdrawn and further diluted five-fold in MES buffer, followed 
by the addition of 200 μL of the okadaic acid solution (1 μg mL-1, 80% methanol). The mixture 
was stirred for 1 h at 25°C. 100 µg lanthanide nanoparticles were dispersed in 700 µl of 50 mM 
borate buffer solution, pH 8.0 and the 300 µL of activated okadaic solution was added. The final 
concentration of nanoparticles was 100 µg mL-1 and okadaic acid was 200 ng mL-1. The mixture 
was stirred for 2 h at 25°C. (Note that contact with okadaic acid may cause severe diarrhea, 
nausea and vomiting, thus requiring appropriate protection measures to be taken.) 
 
Antibody labeling and binding to okadaic acid-decorated LaF3:Ce,Tb nanoparticles 
In a typical experiment, anti-okadaic acid rabbit polyclonal IgG was labeled with goat anti-
rabbit IgG Fab fragment conjugated with AlexaFluor 488 using the Zenon Rabbit IgG labeling kit 
following the manufacturer’s protocol. Briefly, an aliquot of 1 μL rabbit polyclonal IgG was 
diluted with 9 μL phosphate-buffered saline (PBS), pH 7.6, and mixed with 5 μL (1 μg) goat 
anti-rabbit IgG Fab fragment conjugated with AlexaFluor488 (AF488) fluorescent dye (in PBS 
buffer solution) following the manufacturer’s protocol. After labeling, this solution was added to 
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the dispersion of okadaic acid-decorated LaNPs and gently mixed for 30 min at 25°C. The 
fluorescence spectrum was measured (Scheme 1), upon which further aliquots of rabbit serum 
containing IgG anti-okadaic acid antibodies were sequentially added to the solution, incubated 
and the fluorescence measurement repeated. 
 
 
Scheme 1 Luminescence resonance energy transfer between LaNP donor and AlexaFluor488 
acceptor upon okadaic acid-antibody binding 
 
 
Instrumentation 
X-ray diffraction data were collected on a Rigaku Ultima IV multi-purpose diffractometer 
in parafocusing geometry, operating at 40kV and 40mA, and using Cu Kα radiation of 
wavelength 1.5418Å, scan speed of 1° min-1 (2θ) and step size of 0.02° (2θ). Data were 
processed on Rigaku PDXL proprietary software. Atomic force microscopy was performed on 
samples deposited from borate buffer solution (pH 8, 0.05 M) on freshly cleaved mica surfaces 
using a Multimode AFM, with Nanoscope IIIa controller (Bruker, Billerica USA) with a vertical 
engagement (JV) 125 μm scanner, in tapping mode using silicon tips (RTESP, Bruker, tip radius 
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nom. 8 nm). Processing and analysis of images was done on NanoScope software (Digital 
Instruments, version V614r1). Luminescence measurements were carried out on a Kontron 
SFM25 spectrofluorometer and Cary Eclipse fluorescence spectrophotometer at 25°C using 
quartz cuvettes of 1 cm optical path length, with samples dispersed in borate buffer solution (pH 
8, 0.05 M). Time resolved fluorescence lifetime measurements were recorded using the fourth 
harmonic of a 1 kHz laser system (Coherent Inc.), consisting of a Ti:SA oscillator (Mira 900) 
and a Ti:SA amplifier (Legend), at a laser repetition rate of 100 Hz. 
 
Results and Discussion 
The as-prepared dry, powdered nanoparticles gave X-ray diffraction peaks which showed a 
good match to a hexagonal crystal phase (ICDD card 01-070-3182) of LaF3 (Figure 1). No phase 
separation of the cerium and terbium dopants was found, while whole pattern fitting with 
pseudo-Voigt shaped peaks indicated an average crystallite size of 2.6 nm based on applying the 
Scherrer formula to the seven main reflections. AFM measurements on LaNPs (5 μL of a borate 
buffer solution with nanoparticles at a concentration of 20 μg mL-1), gave an average particle 
diameter of 23.9±5 nm (Figure 2), while dim spots of <2 nm size noted on the AFM image are 
likely excess O-phosphorylethanolamine organic ligand used in the synthesis to maintain small 
particle sizes and which was not efficiently removed by the washing steps. While solutions of 
antibodies, LaNPs and okadaic acid-functionalized LaNPs gave stable dispersions individually, 
the corresponding functionalized LaNP-okadaic acid-antibody complexes showed some 
agglomeration behavior, with small agglomerates typically ranging in size from about 100 – 
200 nm by AFM (Figure 3). While unambiguous identification of the components of these small 
agglomerates is not possible by AFM, their sizes are consistent with dynamic light scattering 
data where hydrodynamic diameters of 19.4 nm and 184.9 nm were noted for nanoparticles and 
agglomerates, respectively (data not shown). Considering hydrodynamic radii for the IgG 
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antibody, Fab fragment and nanoparticle of 5.41 nm, 2.91 nm and 9.70 nm respectively and 
taking the average number of antibodies associated with each nanoparticle as 50, the LaNP-
okadaic acid-antibody complexes would show a hydrodynamic diameter of 71.2 nm.26,27 This 
gives an indication that agglomerates could consist of 2-3 LaNP-okadaic acid-antibody 
complexes associated together. The reason for such small agglomerates forming can not be 
established here but may be related to surface energy considerations and/or mediation by other 
molecules in solution derived from the rabbit whole serum. 
 
Figure 1 Powder X-ray diffraction data, simulated pattern (Fitted) based on crystallographic 
database values (DB pattern) and residual plot for LaF3:Ce,Tb nanoparticles 
 
 
 
Figure 2 (a) AFM height image of LaF3:Ce,Tb nanoparticles with (b) height analysis along 
indicated lines (scale bar = 500 nm). 
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 Figure 3 (a) AFM height image of okadaic acid-decorated LaF3:Ce,Tb nanoparticles 
incubated with Fab-AlexaFluor488 labeled anti-okadaic acid antibodies (scale bar = 
1 μm) with (b) height analysis along indicated lines. (c) Deflection image of an 
agglomerate (scale bar = 500 nm). 
 
 
Excitation and emission spectra for LaNPs and AF488 are given in Figure 4. The LaNP 
donor and AF488 acceptor excitation bands are widely separated thus minimizing fluorescence 
due to off-peak excitation of the acceptor. Further, as AF488 has a fast decay lifetime of 4 ns, 
time gating removes any fluorescence signal arising from direct excitation. The nanoparticle 5D4 
→ 7F6 (Tb3+) emission line at 490 nm shows excellent overlap with the AF488 excitation band 
centered at 495 nm, while the AF488 emission at 518 nm does not overlap with other emission 
lines from the nanoparticle thus indicating the appropriateness of the selected donor-acceptor 
pair for interrogating antigen-antibody binding by luminescence resonance energy transfer. 
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Figure 4 Excitation (Ex) and emission (Em) spectra of LaF3:Ce,Tb nanoparticle (LaNP) 
donor and AlexaFluor 488 (AF488) acceptor 
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The emission spectrum of the LaNP-OA-antiOA-AF488 complex under UV excitation at 
282 nm is shown in Figure 5. With increasing concentrations of labeled antibodies a gradual 
increase in the intensity of the 518 nm AF488 emission was noted with a concomitant decrease 
in intensity of the 490 nm LaNP emission. The dynamic response in terms of I518/I490 intensity 
ratio at peak maximum of these bands showed a linear dependence on antibody concentration, 
and hence binding events, in the nano- (83 nM) to micromolar (1.33 µM) range (Figure 5, inset) 
with a limit of detection calculated at 42 nM. Indeed, using this ratio reduces or eliminates 
instrumental counting variability between samples and non-specific sample absorbance based 
on, for example, turbidity. The donor component is necessarily kept in excess as significant self-
quenching would occur for the case where acceptor is in excess. The linear relationship between 
antibody-antigen binding and fluorescence signal measured here indicates that self-quenching in 
this LRET system is minimized despite a relatively small Stokes′ shift and some overlap 
between the AF488 excitation and emission bands. Further, any agglomeration- de-
agglomeration processes for the detection complexes in solution were not found to affect the 
LRET signal over time. 
 
 
Figure 5 Emission spectra of the LaNP-OA-antiOA antibody-AF488 complex (λex 282 nm) 
for various concentrations of labeled antibodies. Inset: corresponding I518/I490 
intensity ratios at peak maxima for different antibody concentrations 
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A corresponding series of control measurements was made for the complex in which no 
OA had been conjugated to the LaNPs to determine the role of non-specific binding in the LRET 
process. In the absence of specific antibody-antigen binding no reduction in 490 nm emission 
intensity was noted for the LaNPs and no increase in AF488 emission at 518 nm was found, 
indicating that achieving successful resonance energy transfer in this system is essentially a 
function of specific molecular recognition between OA and anti-OA antibodies.   
 
Such an absence, or very low-level, of non-specific binding is surprising although may be 
related to steric reasons as LRET shows extreme sensitivity to distance. This means that a 
sufficiently close approach by the AF488 acceptor to the donor may be disfavored due to 
hindrance by the specific, and perhaps non-random, orientation of anti-OA antibody-Fab complex 
with respect to LaNP as has been noted for other systems.28 
 
Further confirmation of resonance energy transfer within the system was obtained through 
photoluminescence lifetime measurements which, using a longer gated delay of 500 µs, avoids 
interference from direct excitation of the AF488 acceptor. For excitation at 266 nm, data showed 
a mono-exponential decay more than 13% faster for the LaNP-OA-anti-OA antibody-AF488 
complex (1.91 ms) compared to the LaNP only (2.20 ms) indicating increased de-excitation 
efficiency based on energy transfer to the short fluorescence lifetime acceptor. 
 
While much published work has used, for example, streptavidin/avidin-biotin binding for 
demonstrating proof of concept in resonance energy transfer systems due to their extremely high 
mutual affinity,29,30 whole serum-derived polyclonal antibodies were interrogated in this work as 
they may be more relevant in a clinical setting. In addition, functionalizing nanoparticles with 
other OA-group congeners (which have only minor structural changes from the okadaic acid 
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used here) would still be expected to give a FRET signal as polyclonal antibodies are able to 
recognize multiple epitopes within a specific toxin group or class giving better cross-reactivity 
and ultimately more robust binding ability to the biotoxin. Indeed, the relative ease with which 
resonance energy transfer was detected in our system, particularly due to the acceptor emission 
band at 518 nm not overlapping with other LaNP donor emission lines and hence avoiding the 
need for peak deconvolution after data acquisition, demonstrates the potential of the technique to 
detect an immune system response to marine biotoxins. Further, the relative lack of non-specific 
binding and the linear response in intensity of emission with number of binding events shows 
promise for the development of such a sensor for these small target biomolecules. This concept 
allowed a ‘test tube’ diagnostic design, in this particular case for okadaic acid antibody 
detection, where all the reactants such as functionalized lanthanide nanoparticles and antibody 
labels, are present in different solutions and require only simple mixing for binding to occur 
without additional precipitation of complexes and washing steps such as, for example, in 
competitive ELISA. 
 
Conclusions 
To our knowledge, this work represents the first use of lanthanide nanoparticle-based 
luminescence resonance energy transfer to labeled antibodies in order to achieve a robust, 
simple, sensitive and quantitative ’test tube’ method for the detection of antibodies against 
marine biotoxins. This work represents a step towards the development of an integrated ‘mix-
and-shake’ solution-based technique which may be applied at point-of-care and does not need 
highly trained personnel or expensive specialized laboratory equipment but rather a simple hand-
held fluorometer. Future work should extend this research to an integrated system in which a 
LRET signal may be detected, for example, by conformational changes upon antibody-antigen 
binding which may eliminate the antibody labeling step. We expect our work will stimulate 
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further research in the area of physical chemistry to answer important questions, for example 
determining antigen orientation with respect to the nanoparticle surface and how this modulates 
its interaction with antibodies, near-surface steric effects and how it affects antibody-antigen 
binding, impact of tailoring the length and flexibility of the nanoparticle-antigen linkers etc. 
Ultimately, such research is expected to have a strong impact on developing strategies for 
tailored biosensors which will find use in the priority areas of point-of-care medical diagnostics, 
consumer health, and food quality and safety monitoring. 
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